Trials / Conditions / BRAF Mutation-Related Tumors
BRAF Mutation-Related Tumors
3 registered clinical trials studyying BRAF Mutation-Related Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | XL092 and Cemiplimab in BRAF WT Thyroid Cancer NCT06902376 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924 | Institut de Recherches Internationales Servier | Phase 1 / Phase 2 |
| Active Not Recruiting | Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer NCT04238624 | Memorial Sloan Kettering Cancer Center | Phase 2 |